243 patents currently held
27 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
62
Ending by 2030
Nov 2026
Next term end
128
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2029 · High confidence
Also notable
Ends Mar 2032 · Medium confidence
Also notable
Ends Sep 2033 · High confidence
Method, Systems, and Computer Program Products for Implementing Function-Parallel Network Firewall
US 8,037,517
The most cited patent in this portfolio, cited by 398 later US patents, top 1% of utility patents granted in 2011 in our data. Protection runs to 2029.
Delivery System
US 10,118,005
Cited by 68 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
Amniotic Membrane Hydrogel and Methods of Making
US 10,016,464
Cited by 36 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Dec 2 to 30, 2026 · next Dec 2
- 3 fees due Jan 11 to 28, 2027 · next Jan 11
- 5 fees due Feb 4 to 22, 2027 · next Feb 4
- 6 fees due Mar 3 to 24, 2027 · next Mar 3
- 5 fees due Apr 8 to 30, 2027 · next Apr 8
- 5 fees due May 7 to 28, 2027 · next May 7
- 6 fees due Jun 3 to 30, 2027 · next Jun 3
- 3 fees due Jul 16 to 23, 2027 · next Jul 16
- 2 fees due Aug 2 to 25, 2027 · next Aug 2
- 6 fees due Sep 15 to 29, 2027 · next Sep 15
- 4 fees due Oct 5 to 28, 2027 · next Oct 5
- 2 fees due Nov 7 to 10, 2027 · next Nov 7
Recent changes
- 5 of the patents on this record were granted since Aug 17, 2026
- 3 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 128 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Regeneration of pancreatic islets by amniotic fluid stem cell therapy | 54 in force | to Nov 2041 |
| Compounds Useful for Multi-Level Specific Targeting of Cancer Cells | 6 in force | to Oct 2031 |
| Medical Tools for Facilitating Deep Lamellar Endothelial Keratoplasty and Related Methods | 6 in force | to Apr 2031 |
| Systemic Gene Replacement Therapy for Treatment of X-Linked Myotubular Myopathy (XLMTM) | 5 in force | to Feb 2034 |
| Molecular Signature of Cancer | 5 in force | to Mar 2029 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,531,503 | Cell Scaffold Matrices with Incorporated Therapeutic Agents In force · High confidence | In force | High confidence | |
| US 8,673,002 | Medical Tools for Facilitating Keratoplasty and Related Methods In force · High confidence | In force | High confidence | |
| US 9,433,495 | Medical Tools for Small Incision Eye Surgery In force · High confidence | In force | High confidence | |
| US 10,959,835 | Medical Kits and Methods for Small Incision Eye Surgery In force · High confidence | In force | High confidence | |
| US 10,821,211 | Coatings and Biomedical Implants Formed from Keratin Biomaterials In force · High confidence | In force | High confidence | |
| US 9,493,735 | Bioreactor System and Method of Enhancing Functionality of Muscle Cultured in Vitro In force · High confidence | In force | High confidence | |
| US 9,290,558 | Molecular Signature of Cancer In force · High confidence | In force | High confidence | |
| US 9,974,830 | Molecular Signature of Cancer In force · High confidence | In force | High confidence | |
| US 10,195,314 | Fractionation of Charged Keratin In force · High confidence | In force | High confidence | |
| US 9,737,455 | Apparatus and Method for Wound Treatment Employing Periodic Sub-Atmospheric Pressure In force · High confidence | In force | High confidence |
Also on record, not counted in the 243: 27 patents in force now held by others · 120 patents ended · 88 applications pending · 194 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.